tradingkey.logo
tradingkey.logo
Search

Agilent Technologies Inc

A
Add to Watchlist
139.760USD
+6.300+4.72%
Close 07-23 16:00ETQuotes delayed by 15 min
39.44BMarket Cap
30.72P/E TTM

Agilent Technologies Inc

139.760
+6.300+4.72%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+4.72%

5 Days

+2.69%

1 Month

+10.33%

6 Months

+3.49%

Year to Date

+2.71%

1 Year

+16.98%

Key Figures
139.750Open
141.870High
2.94MVolume
30.72P/E TTM
21.20P/E Dynamic
1.254Dividend TTM
1.04%Turnover Ratio
133.460Prev. Close
137.530Low
182.23MTurnover
30.27P/E Static
5.54P/B
0.90%Div Yield TTM
10.43%ROA
160.27052wk High
1.09Volume Ratio
1.30BNet Profit
282.22MShares
4.5500EPS TTM
1.26Beta
19.95%ROE
108.35052wk Low
3.25%Amplitude
54.11%Gross Margin
39.44BMarket Cap
0.85Reward/Risk
1.64%Risk Rate

Key Insights

Agilent Technologies Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 22 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 159.56.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Agilent Technologies Inc's Score

Industry at a Glance

Industry Ranking
22 / 200
Overall Ranking
72 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

31°C

Very Low
Very High
Neutral

Agilent Technologies Inc Highlights

StrengthsRisks
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.55%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 21.55%.
Fairly Valued
The company’s latest PE is 30.71, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 245.79M shares, decreasing 8.27% quarter-over-quarter.
Held by Jerome Dodson | PARNX
Star Investor Jerome Dodson | PARNX holds 577.26K shares of this stock.

Analyst Rating

Based on 24 analysts
Buy
Current Rating
159.560
Target Price
+20.10%
Upside Space

Agilent Technologies Inc News

More news coming soon, stay tuned...

Indicators

Indicators
Sell(1)
Neutral(1)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
0.161
Buy
RSI(14)
63.912
Neutral
STOCH(KDJ)(9,3,3)
75.286
Buy
ATR(14)
4.255
High Vlolatility
CCI(14)
204.110
Overbought
Williams %R
13.038
Overbought
TRIX(12,20)
0.141
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
133.556
Buy
MA10
134.212
Buy
MA20
133.389
Buy
MA50
128.459
Buy
MA100
121.949
Buy
MA200
131.015
Buy

Agilent Technologies Inc Info

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Ticker SymbolA
CompanyAgilent Technologies Inc
CEOMcdonnell (Padraig)
Websitehttps://www.agilent.com/

FAQs

What is the current price of Agilent Technologies Inc (A)?

The current price of Agilent Technologies Inc (A) is 139.76.

What is the symbol of Agilent Technologies Inc?

The ticker symbol of Agilent Technologies Inc is A.

What is the 52-week high of Agilent Technologies Inc?

The 52-week high of Agilent Technologies Inc is 160.27.

What is the 52-week low of Agilent Technologies Inc?

The 52-week low of Agilent Technologies Inc is 108.35.

What is the market capitalization of Agilent Technologies Inc?

The market capitalization of Agilent Technologies Inc is 39.44B.

Is Agilent Technologies Inc (A) currently rated as Buy, Hold, or Sell?

According to analysts, Agilent Technologies Inc (A) has an overall rating of Buy, with a price target of 159.56.

What is the Earnings Per Share (EPS TTM) of Agilent Technologies Inc (A)?

The Earnings Per Share (EPS TTM) of Agilent Technologies Inc (A) is 4.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.